Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel Free CLX Stock Alerts

Clorox (CLX) Financials

Clorox logo
$106.00 -1.90 (-1.76%)
Closing price 08/20/2026 03:58 PM Eastern
Extended Trading
$106.49 +0.49 (+0.46%)
As of 08/20/2026 06:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Clorox

Annual Income Statements for Clorox

This table shows Clorox's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 648 701 823 820 939 710 462 149 280 810 587
Consolidated Net Income / (Loss)		 648 701 823 820 939 719 471 161 292 824 601
Net Income / (Loss) Continuing Operations		 648 703 823 820 939 719 471 161 292 824 601
Total Pre-Tax Income 		983 1,033 1,054 1,024 1,185 900 607 238 398 1,078 791
Total Operating Income		 1,064 1,127 1,136 1,124 1,274 927 750 408 683 1,080 913
Total Gross Profit		 2,598 2,671 2,675 2,728 3,063 3,199 2,545 2,908 3,048 3,213 2,844
Total Revenue		 5,761 5,973 6,124 6,214 6,721 7,341 7,107 7,389 7,093 7,104 6,720
Operating Revenue		 5,761 5,973 6,124 6,214 6,721 7,341 7,107 7,389 7,093 7,104 6,720
Total Cost of Revenue		 3,163 3,302 3,449 3,486 3,658 4,142 4,562 4,481 4,045 3,891 3,876
Operating Cost of Revenue		 3,163 3,302 3,449 3,486 3,658 4,142 4,562 4,481 4,045 3,891 3,876
Total Operating Expenses		 1,534 1,544 1,539 1,604 1,789 2,272 1,795 2,500 2,365 2,133 1,931
Selling, General & Admin Expense		 806 810 837 856 969 1,004 954 1,183 1,167 1,124 1,066
Marketing Expense		 587 599 570 612 675 790 709 734 832 770 749
Research & Development Expense		 141 135 132 136 145 149 132 138 126 121 116
Other Special Charges / (Income)		 - - - - - - 0.00 0.00 240 118 0.00
Total Other Income / (Expense), net		 -81 -94 -82 -100 -89 -27 -143 -170 -285 -2.00 -122
Interest Expense		 88 88 85 97 99 99 106 90 90 88 130
Other Income / (Expense), net		 7.00 -6.00 3.00 -3.00 10 72 -37 -80 -195 86 8.00
Income Tax Expense		 335 330 231 204 246 181 136 77 106 254 190
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - - 0.00 0.00 9.00 9.00 12 12 14 14
Basic Earnings per Share		 $5.01 $5.43 $6.37 $6.42 $7.46 $5.66 $3.75 $1.21 $2.26 $6.56 $4.82
Weighted Average Basic Shares Outstanding		 129.47M 128.95M 129.29M 127.73M 125.83M 125.57M 123.11M 123.59M 124.17M 123.53M 121.78M
Diluted Earnings per Share		 $4.92 $5.33 $6.26 $6.32 $7.36 $5.58 $3.73 $1.20 $2.25 $6.52 $4.81
Weighted Average Diluted Shares Outstanding		 131.72M 131.57M 131.58M 129.79M 127.67M 127.30M 123.91M 124.18M 124.80M 124.29M 122.13M
Weighted Average Basic & Diluted Shares Outstanding		 129.47M 129.10M 129.20M 127.70M 126.21M 122.81M 123.16M 123.83M 123.86M 122.31M 120.93M

Quarterly Income Statements for Clorox

This table shows Clorox's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 93 -51 216 99 193 186 332 80 157 187 163
Consolidated Net Income / (Loss)		 96 -50 221 103 194 191 336 82 161 191 167
Net Income / (Loss) Continuing Operations		 96 -50 221 103 194 191 336 82 161 191 167
Total Pre-Tax Income 		136 -42 275 177 237 254 410 107 215 256 213
Total Operating Income		 326 -22 317 176 236 243 425 125 241 289 258
Total Gross Profit		 866 766 884 807 738 744 924 596 722 722 804
Total Revenue		 1,990 1,814 1,903 1,762 1,686 1,668 1,988 1,429 1,673 1,670 1,948
Operating Revenue		 1,990 1,814 1,903 1,762 1,686 1,668 1,988 1,429 1,673 1,670 1,948
Total Cost of Revenue		 1,124 1,048 1,019 955 948 924 1,064 833 951 948 1,144
Operating Cost of Revenue		 1,124 1,048 1,019 955 948 924 1,064 833 951 948 1,144
Total Operating Expenses		 540 788 567 631 502 501 499 471 481 433 546
Selling, General & Admin Expense		 322 301 268 281 280 267 296 277 262 229 298
Marketing Expense		 186 215 266 201 191 207 171 166 190 177 216
Research & Development Expense		 32 32 33 31 31 27 32 28 29 27 32
Total Other Income / (Expense), net		 -190 -20 -42 1.00 1.00 11 -15 -18 -26 -33 -45
Interest Expense		 26 22 21 21 22 23 22 23 25 27 55
Other Income / (Expense), net		 -164 2.00 -21 22 23 34 7.00 5.00 -1.00 -6.00 10
Income Tax Expense		 40 8.00 54 74 43 63 74 25 54 65 46
Net Income / (Loss) Attributable to Noncontrolling Interest		 3.00 1.00 5.00 4.00 1.00 5.00 4.00 2.00 4.00 4.00 4.00
Basic Earnings per Share		 $0.75 ($0.41) $1.75 $0.80 $1.55 $1.51 $2.70 $0.65 $1.29 $1.54 $1.34
Weighted Average Basic Shares Outstanding		 124.18M 124.25M 124.17M 123.80M 123.77M 123.37M 123.53M 122.63M 121.60M 121.36M 121.78M
Diluted Earnings per Share		 $0.75 ($0.41) $1.74 $0.80 $1.54 $1.50 $2.68 $0.65 $1.29 $1.54 $1.33
Weighted Average Diluted Shares Outstanding		 124.62M 124.25M 124.80M 124.68M 124.66M 124.07M 124.29M 123.02M 121.92M 121.79M 122.13M
Weighted Average Basic & Diluted Shares Outstanding		 124.11M 124.19M 123.86M 123.78M 123.19M 123.25M 122.31M 121.98M 120.91M 120.92M 120.93M

Annual Cash Flow Statements for Clorox

This table details how cash moves in and out of Clorox's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Change in Cash & Equivalents		 19 14 -285 -21 766 -555 -138 182 -231 -132 -91
Net Cash From Operating Activities		 778 865 976 992 1,546 1,276 786 1,158 695 981 612
Net Cash From Continuing Operating Activities		 768 868 976 992 1,546 1,276 786 1,158 599 886 542
Net Income / (Loss) Continuing Operations		 648 703 823 820 939 719 471 161 292 824 601
Consolidated Net Income / (Loss)		 648 701 823 820 939 719 471 161 292 824 601
Depreciation Expense		 165 163 166 180 180 211 224 236 206 198 219
Non-Cash Adjustments To Reconcile Net Income		 46 84 97 14 99 387 184 556 442 95 -481
Changes in Operating Assets and Liabilities, net		 -91 -82 -110 -22 328 -41 -93 205 -341 -231 203
Net Cash From Investing Activities		 -430 -205 -859 -196 -252 -452 -229 -223 -175 -94 -2,301
Net Cash From Continuing Investing Activities		 -430 -205 -859 -196 -252 -452 -229 -223 -175 -94 -2,301
Purchase of Property, Plant & Equipment		 -172 -231 -194 -206 -254 -331 -251 -228 -212 -220 -207
Acquisitions		 -290 0.00 -681 0.00 0.00 -85 - - 0.00 0.00 -2,104
Divestitures		 - - - - - - 0.00 0.00 17 128 0.00
Other Investing Activities, net		 32 26 16 10 2.00 -36 22 5.00 20 -2.00 10
Net Cash From Financing Activities		 -316 -645 -399 -815 -523 -1,391 -689 -753 -655 -924 1,668
Net Cash From Continuing Financing Activities		 -316 -645 -399 -815 -523 -1,391 -689 -753 -655 -924 1,668
Repayment of Debt		 -300 -125 -614 - 0.00 0.00 -1,405 -188 0.00 0.00 -1,250
Repurchase of Common Equity		 -254 -183 -271 -661 -248 -905 -25 0.00 0.00 -332 -256
Payment of Dividends		 -398 -412 -450 -490 -533 -589 -586 -598 -611 -618 -618
Issuance of Debt		 426 0.00 891 189 96 0.00 1,322 - -45 0.00 3,815
Issuance of Common Equity		 210 75 45 147 162 103 5.00 33 1.00 26 -23
Cash Interest Paid		 79 78 75 87 89 89 89 99 102 97 122
Cash Income Taxes Paid		 323 347 245 207 241 303 100 73 347 264 104

Quarterly Cash Flow Statements for Clorox

This table details how cash moves in and out of Clorox's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -162 -137 -14 75 12 -65 -59 -1.00 60 958 -1,108
Net Cash From Operating Activities		 153 182 340 221 180 286 294 93 311 -122 330
Net Cash From Continuing Operating Activities		 153 182 340 221 180 286 294 93 311 -122 260
Net Income / (Loss) Continuing Operations		 96 -50 221 103 194 191 336 82 161 191 167
Consolidated Net Income / (Loss)		 96 -50 221 103 194 191 336 82 161 191 167
Depreciation Expense		 57 58 59 54 53 55 57 56 55 58 50
Non-Cash Adjustments To Reconcile Net Income		 194 274 27 120 37 10 2.00 -2.00 16 -464 -31
Changes in Operating Assets and Liabilities, net		 -194 -100 33 -56 -104 30 -101 -43 79 93 74
Net Cash From Investing Activities		 -33 -38 -81 89 -54 -53 -76 -34 -43 -43 -2,181
Net Cash From Continuing Investing Activities		 -33 -38 -81 89 -54 -53 -76 -34 -43 -43 -2,181
Purchase of Property, Plant & Equipment		 -52 -55 -81 -39 -53 -53 -75 -36 -42 -43 -86
Other Investing Activities, net		 19 - - 0.00 -1.00 - -1.00 2.00 -1.00 - 9.00
Net Cash From Financing Activities		 -259 -278 -273 -237 -109 -299 -279 -59 -210 1,126 811
Net Cash From Continuing Financing Activities		 -259 -278 -273 -237 -109 -299 -279 -59 -210 1,126 811
Payment of Dividends		 -149 -148 -165 -151 -151 -166 -150 -151 -151 -150 -166
Issuance of Debt		 - - -106 0.00 - - - - - 1,278 2,234
Issuance of Common Equity		 -7.00 4.00 -2.00 21 8.00 1.00 -4.00 7.00 -21 -2.00 -7.00

Annual Balance Sheets for Clorox

This table presents Clorox's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Assets		 4,510 4,573 5,060 5,116 6,213 6,334 6,158 5,945 5,751 5,561 7,794
Total Current Assets		 1,485 1,514 1,311 1,305 2,020 1,829 1,725 1,828 1,622 1,608 1,824
Cash & Equivalents		 401 418 131 111 871 319 183 367 202 167 143
Accounts Receivable		 569 565 600 631 648 604 681 688 695 821 791
Inventories, net		 443 459 506 512 454 752 755 696 637 523 777
Prepaid Expenses		 72 72 74 51 47 154 106 77 88 97 113
Plant, Property, & Equipment, net		 906 931 996 1,034 1,103 1,302 1,334 1,345 1,315 1,267 1,512
Total Noncurrent Assets		 2,119 2,128 2,753 2,777 3,090 3,203 3,099 2,772 2,814 2,686 4,458
Goodwill		 1,197 1,196 1,602 1,591 1,577 1,575 1,558 1,252 1,228 1,229 1,945
Intangible Assets		 735 722 929 912 894 918 884 712 681 566 1,595
Other Noncurrent Operating Assets		 187 210 222 274 619 710 657 808 905 891 918
Total Liabilities & Shareholders' Equity		 4,510 4,573 5,060 5,116 6,213 6,334 6,158 5,945 5,751 5,561 7,794
Total Liabilities		 4,213 4,031 4,334 4,557 5,305 5,742 5,429 5,557 5,259 5,079 7,542
Total Current Liabilities		 1,558 1,809 1,200 1,440 1,418 2,056 1,784 1,917 1,574 1,919 2,773
Short-Term Debt		 523 804 199 396 0.00 300 237 50 4.00 4.00 1,087
Accounts Payable		 1,035 1,005 1,001 1,035 1,329 1,675 1,469 1,659 1,486 1,828 1,600
Other Current Liabilities		 - - - 0.00 64 81 78 87 84 87 86
Total Noncurrent Liabilities		 2,655 2,222 3,134 3,117 3,887 3,686 3,645 3,640 3,685 3,160 4,769
Long-Term Debt		 2,573 2,161 3,062 2,287 2,780 2,484 2,474 2,477 2,481 2,484 3,981
Noncurrent Deferred & Payable Income Tax Liabilities		 82 61 72 50 62 67 66 28 22 20 17
Other Noncurrent Operating Liabilities		 - - - 780 1,045 1,135 1,105 1,135 1,182 656 771
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 297 542 726 559 908 592 729 388 492 482 252
Total Preferred & Common Equity		 297 542 726 559 908 411 556 220 328 321 90
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 297 542 726 559 908 411 556 220 328 321 90
Common Stock		 1,027 1,087 1,134 1,205 1,296 1,317 1,333 1,376 1,419 1,450 1,443
Retained Earnings		 2,163 2,440 2,797 3,150 3,567 1,036 1,048 583 250 432 386
Treasury Stock		 -2,323 -2,442 -2,658 -3,194 -3,315 -1,396 -1,346 -1,246 -1,186 -1,404 -1,582
Accumulated Other Comprehensive Income / (Loss)		 -570 -543 -547 -602 -640 -546 -479 -493 -155 -157 -157
Noncontrolling Interest		 - - - - 0.00 181 173 168 164 161 162

Quarterly Balance Sheets for Clorox

This table presents Clorox's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 5,945 5,991 5,908 5,805 5,751 5,497 5,577 5,512 5,528 5,613 6,436
Total Current Assets		 1,828 1,911 1,804 1,661 1,622 1,576 1,632 1,590 1,695 1,728 2,651
Cash & Equivalents		 367 518 355 219 202 278 290 226 166 227 1,187
Accounts Receivable		 688 581 679 673 695 595 603 597 703 671 671
Inventories, net		 696 710 655 674 637 594 592 635 577 608 588
Prepaid Expenses		 77 102 115 95 88 109 147 132 249 222 205
Plant, Property, & Equipment, net		 1,345 1,317 1,314 1,292 1,315 1,242 1,242 1,245 1,251 1,247 1,235
Total Noncurrent Assets		 2,772 2,763 2,790 2,852 2,814 2,679 2,703 2,677 2,582 2,638 2,550
Goodwill		 1,252 1,246 1,252 1,229 1,228 1,233 1,219 1,222 1,227 1,231 1,229
Intangible Assets		 712 703 698 688 681 581 574 569 561 556 551
Other Noncurrent Operating Assets		 808 814 840 935 905 865 910 886 794 851 770
Total Liabilities & Shareholders' Equity		 5,945 5,991 5,908 5,805 5,751 5,497 5,577 5,512 5,528 5,613 6,436
Total Liabilities		 5,557 5,860 5,690 5,550 5,259 5,273 5,456 5,322 5,390 5,578 6,344
Total Current Liabilities		 1,917 2,228 2,022 1,846 1,574 1,579 1,730 2,155 2,234 2,347 3,155
Short-Term Debt		 50 347 247 111 4.00 4.00 189 54 218 307 1,591
Accounts Payable		 1,659 1,678 1,649 1,653 1,486 1,472 1,460 2,016 1,927 1,957 1,479
Other Current Liabilities		 87 88 92 82 84 83 81 85 89 83 85
Total Noncurrent Liabilities		 3,640 3,632 3,668 3,704 3,685 3,694 3,726 3,167 3,156 3,231 3,189
Long-Term Debt		 2,477 2,478 2,479 2,480 2,481 2,482 2,483 2,483 2,485 2,486 2,487
Noncurrent Deferred & Payable Income Tax Liabilities		 28 27 26 24 22 23 22 21 20 19 23
Other Noncurrent Operating Liabilities		 1,135 1,127 1,163 1,200 1,182 1,189 1,221 663 651 726 679
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 388 131 218 255 492 224 121 190 138 35 92
Total Preferred & Common Equity		 220 -37 53 91 328 60 -41 27 -22 -125 -67
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 220 -37 53 91 328 60 -41 27 -22 -125 -67
Common Stock		 1,376 1,377 1,376 1,401 1,419 1,428 1,418 1,435 1,457 1,435 1,446
Retained Earnings		 583 299 241 34 250 31 68 99 200 190 223
Treasury Stock		 -1,246 -1,219 -1,205 -1,189 -1,186 -1,252 -1,346 -1,331 -1,514 -1,591 -1,584
Accumulated Other Comprehensive Income / (Loss)		 -493 -494 -359 -155 -155 -147 -181 -176 -165 -159 -152
Noncontrolling Interest		 168 168 165 164 164 164 162 163 160 160 159

Annual Metrics And Ratios for Clorox

This table displays calculated financial ratios and metrics derived from Clorox's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - - 120,921,351.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 120,921,351.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 4.85
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 1.87% 3.68% 2.53% 1.47% 8.16% 9.22% -3.19% 3.97% -4.01% 0.16% -5.41%
EBITDA Growth		 -78.78% 3.88% 1.64% -0.31% 12.53% -17.35% -22.56% -39.81% 28.19% 91.56% -16.42%
EBIT Growth		 -81.06% 4.67% 1.61% -1.58% 14.54% -22.20% -28.63% -54.00% 48.78% 138.93% -21.01%
NOPAT Growth		 -82.28% 9.35% 15.65% 1.47% 12.16% -26.64% -21.42% -52.57% 81.56% 64.74% -15.97%
Net Income Growth		 11.72% 8.18% 17.40% -0.36% 14.51% -23.43% -34.49% -65.82% 81.37% 182.19% -27.06%
EPS Growth		 0.00% 8.33% 17.45% 0.96% 16.46% -24.18% -33.15% -67.83% 87.50% 189.78% -26.23%
Operating Cash Flow Growth		 -10.98% 11.18% 12.83% 1.64% 55.85% -17.46% -38.40% 47.33% -39.98% 41.15% -37.61%
Free Cash Flow Firm Growth		 -88.70% 73.39% -82.08% 1,253.91% -18.56% -62.18% -23.69% 157.88% -72.17% 190.97% -310.69%
Invested Capital Growth		 11.77% 3.24% 24.83% -18.80% -10.03% 8.52% 6.54% -21.77% 8.91% 1.01% 84.70%
Revenue Q/Q Growth		 0.75% 0.79% 0.72% -1.02% 5.59% -2.41% -0.01% 3.04% -1.61% 1.21% -0.59%
EBITDA Q/Q Growth		 -79.09% 3.46% 1.24% -0.84% 7.57% -19.17% 4.81% 20.77% 5.09% 10.71% -13.04%
EBIT Q/Q Growth		 -81.36% 4.09% 1.15% -1.15% 8.72% -22.74% 5.94% 38.98% 8.44% 13.20% -15.12%
NOPAT Q/Q Growth		 -81.69% 6.15% 1.87% 2.51% 5.33% -19.47% 2.20% 39.13% 10.13% 12.96% -17.58%
Net Income Q/Q Growth		 -3.86% 5.41% 1.98% 3.02% 7.93% -22.61% 0.86% 91.67% 15.87% 16.22% -21.95%
EPS Q/Q Growth		 564.86% 5.34% 2.29% 3.27% 8.24% -22.28% 0.00% 103.39% 15.98% 16.85% -21.92%
Operating Cash Flow Q/Q Growth		 -5.81% 6.40% 1.77% -1.10% 29.37% -21.86% -5.76% 8.94% -11.47% -4.48% 6.25%
Free Cash Flow Firm Q/Q Growth		 -89.96% 265.22% -84.53% 755.06% -27.18% -38.63% -34.31% 13.04% -26.32% -6.92% -567.14%
Invested Capital Q/Q Growth		 44.33% -3.50% 16.99% -21.41% -9.86% -5.33% 1.24% 0.16% 5.63% 12.08% 73.55%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 45.10% 44.72% 43.68% 43.90% 45.57% 43.58% 35.81% 39.36% 42.97% 45.23% 42.32%
EBITDA Margin		 21.45% 21.50% 21.31% 20.94% 21.78% 16.48% 13.18% 7.63% 10.19% 19.50% 16.96%
Operating Margin		 18.47% 18.87% 18.55% 18.09% 18.96% 12.63% 10.55% 5.52% 9.63% 15.20% 13.59%
EBIT Margin		 18.59% 18.77% 18.60% 18.04% 19.10% 13.61% 10.03% 4.44% 6.88% 16.41% 13.71%
Profit (Net Income) Margin		 11.25% 11.74% 13.44% 13.20% 13.97% 9.79% 6.63% 2.18% 4.12% 11.60% 8.94%
Tax Burden Percent		 65.92% 67.86% 78.08% 80.08% 79.24% 79.89% 77.59% 67.65% 73.37% 76.44% 75.98%
Interest Burden Percent		 91.78% 92.15% 92.54% 91.35% 92.29% 90.09% 85.13% 72.56% 81.56% 92.45% 85.88%
Effective Tax Rate		 34.08% 31.95% 21.92% 19.92% 20.76% 20.11% 22.41% 32.35% 26.63% 23.56% 24.02%
Return on Invested Capital (ROIC)		 24.75% 25.23% 25.54% 25.76% 33.95% 25.22% 18.43% 9.51% 18.83% 29.60% 17.39%
ROIC Less NNEP Spread (ROIC-NNEP)		 22.71% 22.71% 23.29% 22.96% 30.80% 24.23% 13.99% 4.60% 9.42% 29.53% 14.83%
Return on Net Nonoperating Assets (RNNOA)		 287.54% 141.88% 104.27% 101.86% 94.07% 70.65% 52.88% 19.32% 47.54% 139.60% 146.37%
Return on Equity (ROE)		 312.29% 167.10% 129.81% 127.63% 128.02% 95.87% 71.31% 28.83% 66.36% 169.20% 163.76%
Cash Return on Invested Capital (CROIC)		 13.63% 22.03% 3.46% 46.52% 44.50% 17.04% 12.10% 33.94% 10.30% 28.60% -42.11%
Operating Return on Assets (OROA)		 24.69% 24.68% 23.65% 22.03% 22.67% 15.92% 11.42% 5.42% 8.34% 20.62% 13.79%
Return on Assets (ROA)		 14.94% 15.44% 17.09% 16.12% 16.58% 11.46% 7.54% 2.66% 4.99% 14.57% 9.00%
Return on Common Equity (ROCE)		 312.29% 167.10% 129.81% 127.63% 128.02% 84.30% 52.20% 20.03% 41.33% 112.74% 91.70%
Return on Equity Simple (ROE_SIMPLE)		 218.18% 129.34% 113.36% 146.69% 103.41% 174.94% 84.71% 73.18% 89.02% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 701 767 887 900 1,010 741 582 276 501 826 694
NOPAT Margin		 12.17% 12.84% 14.48% 14.48% 15.02% 10.09% 8.19% 3.74% 7.06% 11.62% 10.32%
Net Nonoperating Expense Percent (NNEP)		 2.03% 2.52% 2.26% 2.81% 3.15% 0.99% 4.44% 4.91% 9.41% 0.07% 2.56%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - - 27.80% 13.04%
Cost of Revenue to Revenue		 54.90% 55.28% 56.32% 56.10% 54.43% 56.42% 64.19% 60.64% 57.03% 54.77% 57.68%
SG&A Expenses to Revenue		 13.99% 13.56% 13.67% 13.78% 14.42% 13.68% 13.42% 16.01% 16.45% 15.82% 15.86%
R&D to Revenue		 2.45% 2.26% 2.16% 2.19% 2.16% 2.03% 1.86% 1.87% 1.78% 1.70% 1.73%
Operating Expenses to Revenue		 26.63% 25.85% 25.13% 25.81% 26.62% 30.95% 25.26% 33.83% 33.34% 30.03% 28.74%
Earnings before Interest and Taxes (EBIT)		 1,071 1,121 1,139 1,121 1,284 999 713 328 488 1,166 921
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,236 1,284 1,305 1,301 1,464 1,210 937 564 723 1,385 1,140
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 48.01 25.86 20.25 30.06 26.89 49.15 28.97 85.65 51.23 45.64 128.23
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 2.47 2.35 2.40 2.70 3.63 2.75 2.27 2.55 2.37 2.06 1.72
Price to Earnings (P/E)		 22.00 20.00 17.86 20.49 26.01 28.45 34.86 126.46 60.01 18.09 19.66
Dividend Yield		 2.79% 2.94% 3.07% 2.91% 2.19% 2.73% 3.55% 3.10% 3.55% 4.11% 5.20%
Earnings Yield		 4.54% 5.00% 5.60% 4.88% 3.85% 3.51% 2.87% 0.79% 1.67% 5.53% 5.09%
Enterprise Value to Invested Capital (EV/IC)		 5.67 5.36 4.62 6.19 9.35 7.47 5.77 8.31 6.94 6.11 3.21
Enterprise Value to Revenue (EV/Rev)		 2.94 2.77 2.91 3.12 3.92 3.11 2.65 2.87 2.71 2.41 2.47
Enterprise Value to EBITDA (EV/EBITDA)		 13.72 12.90 13.67 14.89 17.98 18.88 20.07 37.54 26.63 12.37 14.59
Enterprise Value to EBIT (EV/EBIT)		 15.83 14.78 15.66 17.28 20.51 22.87 26.38 64.54 39.45 14.69 18.05
Enterprise Value to NOPAT (EV/NOPAT)		 24.17 21.60 20.10 21.52 26.08 30.85 32.32 76.71 38.42 20.75 23.97
Enterprise Value to Operating Cash Flow (EV/OCF)		 21.79 19.15 18.27 19.53 17.03 17.91 23.93 18.28 27.70 17.46 27.17
Enterprise Value to Free Cash Flow (EV/FCFF)		 43.87 24.73 148.57 11.92 19.89 45.64 49.24 21.49 70.23 21.48 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 10.42 5.47 4.49 4.80 3.06 4.70 3.72 6.51 5.05 5.16 20.11
Long-Term Debt to Equity		 8.66 3.99 4.22 4.09 3.06 4.20 3.39 6.38 5.04 5.15 15.80
Financial Leverage		 12.66 6.25 4.48 4.44 3.05 2.92 3.78 4.20 5.05 4.73 9.87
Leverage Ratio		 20.90 10.83 7.60 7.92 7.72 8.36 9.46 10.84 13.29 11.61 18.19
Compound Leverage Factor		 19.18 9.98 7.03 7.23 7.13 7.54 8.05 7.86 10.84 10.74 15.63
Debt to Total Capital		 91.25% 84.55% 81.79% 82.76% 75.38% 82.46% 78.81% 86.69% 83.47% 83.77% 95.26%
Short-Term Debt to Total Capital		 15.41% 22.93% 4.99% 12.21% 0.00% 8.89% 6.89% 1.72% 0.13% 0.13% 20.43%
Long-Term Debt to Total Capital		 75.83% 61.62% 76.80% 70.54% 75.38% 73.58% 71.92% 84.97% 83.34% 83.64% 74.83%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 5.36% 5.03% 5.76% 5.51% 5.42% 3.05%
Common Equity to Total Capital		 8.75% 15.45% 18.21% 17.24% 24.62% 12.17% 16.16% 7.55% 11.02% 10.81% 1.69%
Debt to EBITDA		 2.50 2.31 2.50 2.06 1.90 2.30 2.89 4.48 3.44 1.80 4.45
Net Debt to EBITDA		 2.18 1.98 2.40 1.98 1.30 2.04 2.70 3.83 3.16 1.68 4.32
Long-Term Debt to EBITDA		 2.08 1.68 2.35 1.76 1.90 2.05 2.64 4.39 3.43 1.79 3.49
Debt to NOPAT		 4.41 3.87 3.68 2.98 2.75 3.76 4.66 9.16 4.96 3.01 7.31
Net Debt to NOPAT		 3.84 3.32 3.53 2.86 1.89 3.33 4.34 7.83 4.56 2.81 7.10
Long-Term Debt to NOPAT		 3.67 2.82 3.45 2.54 2.75 3.35 4.25 8.97 4.95 3.01 5.74
Altman Z-Score		 4.74 4.87 4.79 4.98 5.45 3.98 3.54 3.58 3.50 3.74 2.09
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 12.07% 26.80% 30.53% 37.73% 33.37% 44.01%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.95 0.84 1.09 0.91 1.42 0.89 0.97 0.95 1.03 0.84 0.66
Quick Ratio		 0.62 0.54 0.61 0.52 1.07 0.45 0.48 0.55 0.57 0.51 0.34
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 386 670 120 1,625 1,324 501 382 985 274 798 -1,680
Operating Cash Flow to CapEx		 452.33% 374.46% 503.09% 481.55% 608.66% 385.50% 313.15% 507.89% 327.83% 445.91% 295.65%
Free Cash Flow to Firm to Interest Expense		 4.39 7.61 1.41 16.75 13.37 5.06 3.60 10.94 3.05 9.06 -12.93
Operating Cash Flow to Interest Expense		 8.84 9.83 11.48 10.23 15.62 12.89 7.42 12.87 7.72 11.15 4.71
Operating Cash Flow Less CapEx to Interest Expense		 6.89 7.20 9.20 8.10 13.05 9.55 5.05 10.33 5.37 8.65 3.12
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.33 1.32 1.27 1.22 1.19 1.17 1.14 1.22 1.21 1.26 1.01
Accounts Receivable Turnover		 10.59 10.53 10.51 10.10 10.51 11.73 11.06 10.79 10.26 9.37 8.34
Inventory Turnover		 7.64 7.32 7.15 6.85 7.57 6.87 6.05 6.18 6.07 6.71 5.96
Fixed Asset Turnover		 6.32 6.50 6.36 6.12 6.29 6.10 5.39 5.52 5.33 5.50 4.84
Accounts Payable Turnover		 3.14 3.24 3.44 3.42 3.09 2.76 2.90 2.87 2.57 2.35 2.26
Days Sales Outstanding (DSO)		 34.47 34.65 34.72 36.15 34.73 31.13 33.00 33.81 35.58 38.95 43.78
Days Inventory Outstanding (DIO)		 47.77 49.85 51.06 53.29 48.19 53.14 60.29 59.10 60.14 54.41 61.21
Days Payable Outstanding (DPO)		 116.20 112.75 106.15 106.59 117.94 132.36 125.77 127.40 141.89 155.44 161.41
Cash Conversion Cycle (CCC)		 -33.96 -28.25 -20.37 -17.14 -35.02 -48.10 -32.49 -34.49 -46.17 -62.08 -56.42
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,992 3,089 3,856 3,131 2,817 3,057 3,257 2,548 2,775 2,803 5,177
Invested Capital Turnover		 2.03 1.96 1.76 1.78 2.26 2.50 2.25 2.55 2.67 2.55 1.68
Increase / (Decrease) in Invested Capital		 315 97 767 -725 -314 240 200 -709 227 28 2,374
Enterprise Value (EV)		 16,953 16,566 17,833 19,373 26,329 22,847 18,806 21,171 19,251 17,132 16,628
Market Capitalization		 14,258 14,019 14,703 16,801 24,420 20,201 16,105 18,843 16,804 14,650 11,541
Book Value per Share		 $2.30 $4.21 $5.61 $4.39 $7.21 $3.30 $4.52 $1.78 $2.64 $2.60 $0.74
Tangible Book Value per Share		 ($12.64) ($10.68) ($13.94) ($15.26) ($12.41) ($16.74) ($15.32) ($14.11) ($12.73) ($11.96) ($28.53)
Total Capital		 3,393 3,507 3,987 3,242 3,688 3,376 3,440 2,915 2,977 2,970 5,320
Total Debt		 3,096 2,965 3,261 2,683 2,780 2,784 2,711 2,527 2,485 2,488 5,068
Total Long-Term Debt		 2,573 2,161 3,062 2,287 2,780 2,484 2,474 2,477 2,481 2,484 3,981
Net Debt		 2,695 2,547 3,130 2,572 1,909 2,465 2,528 2,160 2,283 2,321 4,925
Capital Expenditures (CapEx)		 172 231 194 206 254 331 251 228 212 220 207
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 49 91 179 150 -269 -246 -5.00 -406 -150 -474 -5.00
Debt-free Net Working Capital (DFNWC)		 450 509 310 261 602 73 178 -39 52 -307 138
Net Working Capital (NWC)		 -73 -295 111 -135 602 -227 -59 -89 48 -311 -949
Net Nonoperating Expense (NNE)		 53 66 64 80 71 22 111 115 209 1.53 93
Net Nonoperating Obligations (NNO)		 2,695 2,547 3,130 2,572 1,909 2,465 2,528 2,160 2,283 2,321 4,925
Total Depreciation and Amortization (D&A)		 165 163 166 180 180 211 224 236 235 219 219
Debt-free, Cash-free Net Working Capital to Revenue		 0.85% 1.52% 2.92% 2.41% -4.00% -3.35% -0.07% -5.49% -2.11% -6.67% -0.07%
Debt-free Net Working Capital to Revenue		 7.81% 8.52% 5.06% 4.20% 8.96% 0.99% 2.50% -0.53% 0.73% -4.32% 2.05%
Net Working Capital to Revenue		 -1.27% -4.94% 1.81% -2.17% 8.96% -3.09% -0.83% -1.20% 0.68% -4.38% -14.12%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $5.01 $0.00 $0.00 $6.42 $7.46 $5.66 $3.75 $1.21 $2.26 $6.56 $4.82
Adjusted Weighted Average Basic Shares Outstanding		 129.47M 0.00 0.00 127.73M 125.83M 125.57M 123.11M 123.59M 124.17M 123.53M 121.78M
Adjusted Diluted Earnings per Share		 $4.92 $0.00 $0.00 $6.32 $7.36 $5.58 $3.73 $1.20 $2.25 $6.52 $4.81
Adjusted Weighted Average Diluted Shares Outstanding		 131.72M 0.00 0.00 129.79M 127.67M 127.30M 123.91M 124.18M 124.80M 124.29M 122.13M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 129.47M 0.00 0.00 125.74M 126.21M 122.81M 123.16M 123.83M 123.86M 122.31M 120.93M
Normalized Net Operating Profit after Tax (NOPAT)		 701 767 887 900 1,010 1,003 582 577 677 916 694
Normalized NOPAT Margin		 12.17% 12.84% 14.48% 14.48% 15.02% 13.67% 8.19% 7.81% 9.55% 12.89% 10.32%
Pre Tax Income Margin		 17.06% 17.29% 17.21% 16.48% 17.63% 12.26% 8.54% 3.22% 5.61% 15.17% 11.77%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 12.17 12.74 13.40 11.56 12.97 10.09 6.73 3.64 5.42 13.25 7.08
NOPAT to Interest Expense		 7.97 8.72 10.44 9.28 10.20 7.48 5.49 3.07 5.57 9.38 5.34
EBIT Less CapEx to Interest Expense		 10.22 10.11 11.12 9.43 10.40 6.75 4.36 1.11 3.07 10.75 5.49
NOPAT Less CapEx to Interest Expense		 6.02 6.09 8.15 7.16 7.63 4.14 3.12 0.53 3.21 6.88 3.74
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 61.42% 58.77% 54.68% 59.76% 56.76% 81.92% 124.42% 371.43% 209.25% 75.00% 102.83%
Augmented Payout Ratio		 100.62% 84.88% 87.61% 140.37% 83.17% 207.79% 129.72% 371.43% 209.25% 115.29% 145.42%

Quarterly Metrics And Ratios for Clorox

This table displays calculated financial ratios and metrics derived from Clorox's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - 120,911,863.00 120,921,351.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 120,911,863.00 120,921,351.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 1.55 1.35
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 16.04% -5.27% -5.75% 27.13% -15.28% -8.05% 4.47% -18.90% -0.77% 0.12% -2.01%
EBITDA Growth		 3.79% 123.60% 10.94% 127.03% 42.47% 773.68% 37.75% -26.19% -5.45% 2.71% -32.05%
EBIT Growth		 5.88% 90.95% 14.73% 296.00% 59.88% 1,485.00% 45.95% -34.34% -7.34% 2.17% -37.96%
NOPAT Growth		 96.84% 88.83% 17.45% 91.62% -16.05% 1,286.55% 36.72% -6.47% -6.58% 18.00% -41.92%
Net Income Growth		 -5.88% 76.08% 22.10% 312.00% 102.08% 482.00% 52.04% -20.39% -17.01% 0.00% -50.30%
EPS Growth		 -6.25% 76.02% 21.68% 370.59% 105.33% 465.85% 54.02% -18.75% -16.23% 2.67% -50.37%
Operating Cash Flow Growth		 -26.79% -46.63% -20.93% 1,005.00% 17.65% 57.14% -13.53% -57.92% 72.78% -142.66% 12.24%
Free Cash Flow Firm Growth		 134.42% -118.39% -97.00% -83.48% -56.99% 413.75% 1,054.09% -235.78% -70.46% -186.28% -778.04%
Invested Capital Growth		 -13.93% 3.26% 8.91% -0.25% -3.32% -4.80% 1.01% 9.99% 3.92% 19.27% 84.70%
Revenue Q/Q Growth		 43.58% -8.84% 4.91% -7.41% -4.31% -1.07% 19.18% -28.12% 17.07% -0.18% 16.65%
EBITDA Q/Q Growth		 97.30% -82.65% 834.21% -29.01% 23.81% 6.41% 47.29% -61.96% 58.60% 15.59% -6.74%
EBIT Q/Q Growth		 224.00% -112.35% 1,580.00% -33.11% 30.81% 6.95% 55.96% -69.91% 84.62% 17.92% -5.30%
NOPAT Q/Q Growth		 330.54% -106.69% 1,754.24% -59.80% 88.62% -5.41% 90.61% -72.50% 88.39% 19.48% -6.19%
Net Income Q/Q Growth		 284.00% -152.08% 542.00% -53.39% 88.35% -1.55% 75.92% -75.60% 96.34% 18.63% -12.57%
EPS Q/Q Growth		 341.18% -154.67% 524.39% -54.02% 92.50% -2.60% 78.67% -75.75% 98.46% 19.38% -13.64%
Operating Cash Flow Q/Q Growth		 665.00% 18.95% 86.81% -35.00% -18.55% 58.89% 2.80% -68.37% 234.41% -139.23% 370.49%
Free Cash Flow Firm Q/Q Growth		 -1.12% -115.16% 128.20% 290.66% 157.50% 10.58% 3.75% -145.96% 156.02% -423.00% -715.27%
Invested Capital Q/Q Growth		 6.19% 1.47% 5.63% -12.36% 2.92% -0.08% 12.08% -4.57% -2.77% 14.69% 73.55%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 43.52% 42.23% 46.45% 45.80% 43.77% 44.60% 46.48% 41.71% 43.16% 43.23% 41.27%
EBITDA Margin		 11.01% 2.09% 18.65% 14.30% 18.51% 19.90% 24.60% 13.02% 17.63% 20.42% 16.32%
Operating Margin		 16.38% -1.21% 16.66% 9.99% 14.00% 14.57% 21.38% 8.75% 14.41% 17.31% 13.24%
EBIT Margin		 8.14% -1.10% 15.55% 11.24% 15.36% 16.61% 21.73% 9.10% 14.35% 16.95% 13.76%
Profit (Net Income) Margin		 4.82% -2.76% 11.61% 5.85% 11.51% 11.45% 16.90% 5.74% 9.62% 11.44% 8.57%
Tax Burden Percent		 70.59% 119.05% 80.36% 58.19% 81.86% 75.20% 81.95% 76.64% 74.88% 74.61% 78.40%
Interest Burden Percent		 83.95% 210.00% 92.91% 89.39% 91.51% 91.70% 94.91% 82.31% 89.58% 90.46% 79.48%
Effective Tax Rate		 29.41% 0.00% 19.64% 41.81% 18.14% 24.80% 18.05% 23.36% 25.12% 25.39% 21.60%
Return on Invested Capital (ROIC)		 30.21% -2.37% 35.68% 17.83% 32.25% 29.99% 44.63% 17.78% 28.57% 31.83% 17.49%
ROIC Less NNEP Spread (ROIC-NNEP)		 24.72% -3.83% 34.16% 17.86% 32.28% 30.34% 44.09% 17.19% 27.78% 30.88% 16.52%
Return on Net Nonoperating Assets (RNNOA)		 170.41% -42.50% 172.46% 227.09% 452.58% 319.31% 208.42% 225.38% 881.09% 569.72% 163.04%
Return on Equity (ROE)		 200.62% -44.87% 208.13% 244.92% 484.83% 349.30% 253.04% 243.15% 909.65% 601.55% 180.53%
Cash Return on Invested Capital (CROIC)		 25.03% 14.39% 10.30% 22.43% 23.46% 33.42% 28.60% 22.59% 27.80% 13.12% -42.11%
Operating Return on Assets (OROA)		 9.96% -1.37% 18.87% 14.61% 19.17% 20.60% 27.29% 11.17% 17.33% 19.18% 13.85%
Return on Assets (ROA)		 5.90% -3.42% 14.09% 7.60% 14.36% 14.20% 21.23% 7.05% 11.62% 12.94% 8.63%
Return on Common Equity (ROCE)		 105.83% -9.88% 129.61% 15.87% 17.16% 92.62% 168.61% 25.52% -967.96% -85.33% 101.08%
Return on Equity Simple (ROE_SIMPLE)		 175.47% 276.92% 0.00% 616.67% -1,141.46% 2,625.93% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 230 -15 255 102 193 183 348 96 180 216 202
NOPAT Margin		 11.56% -0.85% 13.39% 5.81% 11.46% 10.95% 17.52% 6.70% 10.79% 12.91% 10.38%
Net Nonoperating Expense Percent (NNEP)		 5.49% 1.46% 1.52% -0.03% -0.03% -0.35% 0.53% 0.58% 0.79% 0.95% 0.97%
Return On Investment Capital (ROIC_SIMPLE)		 7.82% - - - 6.92% 6.70% 11.73% 3.37% 6.38% 5.17% 3.80%
Cost of Revenue to Revenue		 56.48% 57.77% 53.55% 54.20% 56.23% 55.40% 53.52% 58.29% 56.84% 56.77% 58.73%
SG&A Expenses to Revenue		 16.18% 16.59% 14.08% 15.95% 16.61% 16.01% 14.89% 19.38% 15.66% 13.71% 15.30%
R&D to Revenue		 1.61% 1.76% 1.73% 1.76% 1.84% 1.62% 1.61% 1.96% 1.73% 1.62% 1.64%
Operating Expenses to Revenue		 27.14% 43.44% 29.80% 35.81% 29.77% 30.04% 25.10% 32.96% 28.75% 25.93% 28.03%
Earnings before Interest and Taxes (EBIT)		 162 -20 296 198 259 277 432 130 240 283 268
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 219 38 355 252 312 332 489 186 295 341 318
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 320.47 205.33 51.23 333.73 0.00 666.07 45.64 0.00 0.00 0.00 128.23
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 2.32 2.59 2.37 2.68 2.78 2.56 2.06 2.20 1.80 1.83 1.72
Price to Earnings (P/E)		 212.31 77.85 60.01 56.09 43.65 25.91 18.09 18.87 16.11 16.37 19.66
Dividend Yield		 3.48% 3.17% 3.55% 2.98% 3.00% 3.33% 4.11% 4.02% 4.93% 4.83% 5.20%
Earnings Yield		 0.47% 1.28% 1.67% 1.78% 2.29% 3.86% 5.53% 5.30% 6.21% 6.11% 5.09%
Enterprise Value to Invested Capital (EV/IC)		 7.54 8.08 6.94 9.21 8.99 8.18 6.11 6.59 5.72 5.17 3.21
Enterprise Value to Revenue (EV/Rev)		 2.67 2.94 2.71 3.00 3.14 2.91 2.41 2.60 2.20 2.28 2.47
Enterprise Value to EBITDA (EV/EBITDA)		 39.92 30.84 26.63 25.92 23.50 16.35 12.37 13.36 11.44 11.77 14.59
Enterprise Value to EBIT (EV/EBIT)		 78.40 47.16 39.45 35.21 30.69 19.86 14.69 16.05 13.80 14.22 18.05
Enterprise Value to NOPAT (EV/NOPAT)		 69.38 46.64 38.42 41.47 43.98 27.99 20.75 21.50 18.44 18.33 23.97
Enterprise Value to Operating Cash Flow (EV/OCF)		 20.68 27.03 27.70 25.00 24.37 19.92 17.46 20.66 15.13 26.78 27.17
Enterprise Value to Free Cash Flow (EV/FCFF)		 27.87 57.05 70.23 41.01 37.65 23.88 21.48 30.55 20.99 42.88 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 12.50 10.16 5.05 11.10 22.08 13.35 5.16 19.59 79.80 44.33 20.11
Long-Term Debt to Equity		 11.37 9.73 5.04 11.08 20.52 13.07 5.15 18.01 71.03 27.03 15.80
Financial Leverage		 6.89 11.11 5.05 12.72 14.02 10.52 4.73 13.11 31.72 18.45 9.87
Leverage Ratio		 16.86 27.22 13.29 32.36 33.88 25.43 11.61 30.46 71.73 42.37 18.19
Compound Leverage Factor		 14.15 57.16 12.35 28.93 31.00 23.32 11.02 25.07 64.26 38.33 14.46
Debt to Total Capital		 92.60% 91.04% 83.47% 91.73% 95.67% 93.03% 83.77% 95.14% 98.76% 97.79% 95.26%
Short-Term Debt to Total Capital		 8.39% 3.90% 0.13% 0.15% 6.77% 1.98% 0.13% 7.67% 10.86% 38.15% 20.43%
Long-Term Debt to Total Capital		 84.21% 87.14% 83.34% 91.59% 88.90% 91.05% 83.64% 87.47% 87.91% 59.64% 74.83%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 5.60% 5.76% 5.51% 6.05% 5.80% 5.98% 5.42% 5.63% 5.66% 3.81% 3.05%
Common Equity to Total Capital		 1.80% 3.20% 11.02% 2.21% -1.47% 0.99% 10.81% -0.77% -4.42% -1.61% 1.69%
Debt to EBITDA		 5.57 3.77 3.44 2.88 2.79 2.03 1.80 2.05 2.15 3.11 4.45
Net Debt to EBITDA		 4.85 3.45 3.16 2.56 2.49 1.85 1.68 1.92 1.97 2.21 4.32
Long-Term Debt to EBITDA		 5.07 3.60 3.43 2.87 2.59 1.98 1.79 1.88 1.91 1.90 3.49
Debt to NOPAT		 9.69 5.69 4.96 4.60 5.22 3.47 3.01 3.30 3.46 4.85 7.31
Net Debt to NOPAT		 8.43 5.21 4.56 4.09 4.66 3.16 2.81 3.09 3.18 3.43 7.10
Long-Term Debt to NOPAT		 8.81 5.45 4.95 4.60 4.86 3.40 3.01 3.03 3.08 2.95 5.74
Altman Z-Score		 3.13 3.22 3.39 3.76 3.63 3.37 3.31 2.90 2.57 2.32 1.82
Noncontrolling Interest Sharing Ratio		 47.25% 77.99% 37.73% 93.52% 96.46% 73.48% 33.37% 89.50% 206.41% 114.18% 44.01%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.89 0.90 1.03 1.00 0.94 0.74 0.84 0.76 0.74 0.84 0.66
Quick Ratio		 0.51 0.48 0.57 0.55 0.52 0.38 0.51 0.39 0.38 0.59 0.34
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 649 -98 28 108 279 309 320 -147 82 -266 -2,172
Operating Cash Flow to CapEx		 294.23% 330.91% 419.75% 566.67% 339.62% 539.62% 392.00% 258.33% 740.48% -283.72% 383.72%
Free Cash Flow to Firm to Interest Expense		 24.97 -4.47 1.32 5.16 12.69 13.42 14.56 -6.40 3.30 -9.87 -39.49
Operating Cash Flow to Interest Expense		 5.88 8.27 16.19 10.52 8.18 12.43 13.36 4.04 12.44 -4.52 6.00
Operating Cash Flow Less CapEx to Interest Expense		 3.88 5.77 12.33 8.67 5.77 10.13 9.95 2.48 10.76 -6.11 4.44
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.22 1.24 1.21 1.30 1.25 1.24 1.26 1.23 1.21 1.13 1.01
Accounts Receivable Turnover		 11.43 10.67 10.26 12.70 11.18 11.05 9.37 10.43 10.61 10.66 8.34
Inventory Turnover		 6.09 5.94 6.07 6.36 6.37 5.88 6.71 6.44 6.29 6.21 5.96
Fixed Asset Turnover		 5.55 5.53 5.33 5.84 5.61 5.53 5.50 5.43 5.43 5.45 4.84
Accounts Payable Turnover		 2.63 2.48 2.57 2.63 2.55 2.10 2.35 2.22 2.21 2.17 2.26
Days Sales Outstanding (DSO)		 31.93 34.20 35.58 28.73 32.65 33.02 38.95 34.99 34.40 34.23 43.78
Days Inventory Outstanding (DIO)		 59.95 61.47 60.14 57.40 57.32 62.11 54.41 56.70 58.06 58.80 61.21
Days Payable Outstanding (DPO)		 139.04 147.25 141.89 138.66 142.92 174.10 155.44 164.58 165.32 168.03 161.41
Cash Conversion Cycle (CCC)		 -47.17 -51.57 -46.17 -52.52 -52.94 -78.97 -62.08 -72.90 -72.86 -75.00 -56.42
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,589 2,627 2,775 2,432 2,503 2,501 2,803 2,675 2,601 2,983 5,177
Invested Capital Turnover		 2.61 2.79 2.67 3.07 2.81 2.74 2.55 2.65 2.65 2.47 1.68
Increase / (Decrease) in Invested Capital		 -419 83 227 -6.00 -86 -126 28 243 98 482 2,374
Enterprise Value (EV)		 19,521 21,221 19,251 22,396 22,494 20,458 17,132 17,622 14,891 15,424 16,628
Market Capitalization		 16,985 18,685 16,804 20,024 19,950 17,984 14,650 14,925 12,165 12,374 11,541
Book Value per Share		 $0.43 $0.73 $2.64 $0.48 ($0.33) $0.22 $2.60 ($0.18) ($1.02) ($0.55) $0.74
Tangible Book Value per Share		 ($15.29) ($14.71) ($12.73) ($14.16) ($14.82) ($14.32) ($11.96) ($14.80) ($15.67) ($15.28) ($28.53)
Total Capital		 2,944 2,846 2,977 2,710 2,793 2,727 2,970 2,841 2,828 4,170 5,320
Total Debt		 2,726 2,591 2,485 2,486 2,672 2,537 2,488 2,703 2,793 4,078 5,068
Total Long-Term Debt		 2,479 2,480 2,481 2,482 2,483 2,483 2,484 2,485 2,486 2,487 3,981
Net Debt		 2,371 2,372 2,283 2,208 2,382 2,311 2,321 2,537 2,566 2,891 4,925
Capital Expenditures (CapEx)		 52 55 81 39 53 53 75 36 42 43 86
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -326 -293 -150 -277 -199 -737 -474 -487 -539 -100 -5.00
Debt-free Net Working Capital (DFNWC)		 29 -74 52 1.00 91 -511 -307 -321 -312 1,087 138
Net Working Capital (NWC)		 -218 -185 48 -3.00 -98 -565 -311 -539 -619 -504 -949
Net Nonoperating Expense (NNE)		 134 35 34 -0.58 -0.82 -8.27 12 14 19 25 35
Net Nonoperating Obligations (NNO)		 2,371 2,372 2,283 2,208 2,382 2,311 2,321 2,537 2,566 2,891 4,925
Total Depreciation and Amortization (D&A)		 57 58 59 54 53 55 57 56 55 58 50
Debt-free, Cash-free Net Working Capital to Revenue		 -4.46% -4.06% -2.11% -3.71% -2.78% -10.50% -6.67% -7.19% -7.98% -1.48% -0.07%
Debt-free Net Working Capital to Revenue		 0.40% -1.03% 0.73% 0.01% 1.27% -7.28% -4.32% -4.74% -4.62% 16.08% 2.05%
Net Working Capital to Revenue		 -2.98% -2.57% 0.68% -0.04% -1.37% -8.05% -4.38% -7.96% -9.16% -7.46% -14.12%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.75 ($0.41) $1.75 $0.80 $1.55 $1.51 $2.70 $0.65 $1.29 $1.54 $1.34
Adjusted Weighted Average Basic Shares Outstanding		 124.18M 124.25M 124.17M 123.80M 123.77M 123.37M 123.53M 122.63M 121.60M 121.36M 121.78M
Adjusted Diluted Earnings per Share		 $0.75 ($0.41) $1.74 $0.80 $1.54 $1.50 $2.68 $0.65 $1.29 $1.54 $1.33
Adjusted Weighted Average Diluted Shares Outstanding		 124.62M 124.25M 124.80M 124.68M 124.66M 124.07M 124.29M 123.02M 121.92M 121.79M 122.13M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 124.11M 124.19M 123.86M 123.78M 123.19M 123.25M 122.31M 121.98M 120.91M 120.92M 120.93M
Normalized Net Operating Profit after Tax (NOPAT)		 230 153 255 171 193 183 348 96 180 216 202
Normalized NOPAT Margin		 11.56% 8.41% 13.39% 9.71% 11.46% 10.95% 17.52% 6.70% 10.79% 12.91% 10.38%
Pre Tax Income Margin		 6.83% -2.32% 14.45% 10.05% 14.06% 15.23% 20.62% 7.49% 12.85% 15.33% 10.93%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 6.23 -0.91 14.10 9.43 11.77 12.04 19.64 5.65 9.60 10.48 4.87
NOPAT to Interest Expense		 8.85 -0.70 12.13 4.88 8.78 7.94 15.83 4.17 7.22 7.99 3.68
EBIT Less CapEx to Interest Expense		 4.23 -3.41 10.24 7.57 9.36 9.74 16.23 4.09 7.92 8.89 3.31
NOPAT Less CapEx to Interest Expense		 6.85 -3.20 8.27 3.02 6.37 5.64 12.42 2.60 5.54 6.39 2.11
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 650.54% 240.87% 209.25% 165.68% 131.41% 89.28% 75.00% 76.96% 80.26% 78.18% 102.83%
Augmented Payout Ratio		 650.54% 240.87% 209.25% 194.59% 186.32% 125.53% 115.29% 121.05% 123.25% 121.17% 145.42%

Financials Breakdown Chart

Key Financial Trends

Clorox’s recent results show a business recovering from the severe impairment and profitability pressures reported in 2023 and early 2024, but the recovery remains uneven. Revenue improved from $1.43 billion in Q1 2026 to $1.95 billion in Q4 2026, while quarterly net income remained positive throughout fiscal 2026. However, Q4 earnings declined sharply year over year, and the balance sheet remains highly leveraged.

  • Revenue recovered through fiscal 2026: Quarterly revenue increased from $1.43 billion in Q1 2026 to $1.95 billion in Q4, suggesting improved demand and a typical seasonal benefit in the later fiscal quarters.
  • Profitability has moved well above the 2023 trough: Clorox reported quarterly operating losses and impairment-related losses in parts of 2023 and 2024, while fiscal 2026 produced positive operating income and net income in every reported quarter.
  • Operating cash flow remained solid: Cash flow from operating activities was $330 million in Q4 2026, above $294 million in Q4 2025. Fiscal 2026 also benefited from positive working-capital movements in several quarters.
  • Share count has declined modestly: Diluted shares outstanding fell to approximately 122.1 million in Q4 2026 from 124.3 million in Q4 2025, helped by share repurchases earlier in the fiscal year. This can support per-share results over time.
  • Results remain seasonal and volatile: Revenue and earnings varied substantially between quarters, with Q4 2026 revenue materially higher than Q1 but net income lower than Q3. Investors should evaluate Clorox using annual and year-over-year comparisons rather than sequential changes alone.
  • The Q4 cash-flow statement contains unusually large financing and investing items: Clorox reported $2.23 billion of debt issuance and $2.18 billion of investing cash outflow. The data does not identify the underlying transaction, so investors should review the company’s filing to determine whether this reflects an acquisition, refinancing or another major corporate action.
  • Q4 2026 earnings weakened sharply year over year: Revenue declined about 2% from $1.99 billion in Q4 2025, while net income attributable to common shareholders dropped from $332 million to $163 million. Diluted EPS fell from $2.68 to $1.33.
  • Margins compressed: Q4 2026 gross margin was approximately 41%, down from roughly 46% a year earlier, while operating margin declined to about 13% from 21%. Higher cost of revenue and operating expenses consumed a larger portion of sales.
  • Leverage is a major risk: At March 31, 2026, Clorox had approximately $4.08 billion of short- and long-term debt, compared with $1.19 billion of cash. The company also issued substantial additional debt during Q4, which could increase future interest expense and refinancing risk.
  • Shareholders’ equity is extremely thin: Common equity was negative $67 million at March 31, 2026, and total equity including noncontrolling interests was only $92 million against $6.34 billion of liabilities. Current liabilities also exceeded current assets, highlighting limited balance-sheet flexibility.

Bottom line: Clorox has restored positive earnings and maintained meaningful operating cash generation, but the latest quarter points to renewed margin pressure. The combination of declining year-over-year EPS, heavy debt, negative common equity and the unexplained Q4 financing activity makes balance-sheet improvement and sustainable margin recovery important factors for CLX investors.

08/20/26 11:53 PM ETAI Generated. May Contain Errors.

Clorox Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Clorox's financial year ends in June. Their financial year 2026 ended on June 30, 2026.

Clorox's net income appears to be on a downward trend, with a most recent value of $601 million in 2026, falling from $648 million in 2016. The previous period was $824 million in 2025. See Clorox's forecast for analyst expectations on what's next for the company.

Clorox's total operating income in 2026 was $913 million, based on the following breakdown:
  • Total Gross Profit: $2.84 billion
  • Total Operating Expenses: $1.93 billion

Over the last 10 years, Clorox's total revenue changed from $5.76 billion in 2016 to $6.72 billion in 2026, a change of 16.6%.

Clorox's total liabilities were at $7.54 billion at the end of 2026, a 48.5% increase from 2025, and a 79.0% increase since 2016.

In the past 10 years, Clorox's cash and equivalents has ranged from $111 million in 2019 to $871 million in 2020, and is currently $143 million as of their latest financial filing in 2026.

Over the last 10 years, Clorox's book value per share changed from 2.30 in 2016 to 0.74 in 2026, a change of -67.6%.


Related Companies

Financial statements for NYSE:CLX last updated on 8/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel